Cipla

Showing all 2 results

Showing all 2 results

Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.

Cipla is a leading global pharmaceutical company, dedicated to high-quality, branded and generic medicines. We are trusted by healthcare professionals and patients across geographies. Over the last 8 decades, we have strengthened our leadership in India’s pharmaceutical industry and fortified our promise of ‘Caring for Life’.

We are now strengthening our global focus by consolidating and deepening our presence in the key markets of India, South Africa, the US, and other economies of the emerging world

Cipla’s state-of-the-art manufacturing facilities are cGMP compliant in conformity with national and international standards. Several dosage forms and APIs manufactured at these facilities continue to be approved by major international regulatory agencies including the US FDA, MHRA (UK), TGA (Australia), Federal Ministry of Health-Germany, MCC (South Africa), the Department of Health (Canada), INVIMA (Columbia) ANVISA (Brazil), the Danish Medical Agency, WHO and Ministry of Health of various countries.